Title	Publication Date	Language	Citations
Role of angiogenesis in tumor growth and metastasis	2002/12/01		1,753
Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia	2003/04/01	English	638
Epidermal Growth Factor Receptor Targeting in Cancer	2006/08/01	English	482
Breast Cancer Before Age 40 Years	2009/06/01	English	452
Multiple myeloma epidemiology and survival: A unique malignancy	2016/12/01	English	433
Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: Therapeutic implications	2002/12/01		404
Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity	2004/12/01	English	379
The Next Hurdle in Cancer Immunotherapy: Overcoming the Non–T-Cell–Inflamed Tumor Microenvironment	2015/08/01	English	336
A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer	2003/10/01	English	309
Cancer Prevention With Natural Compounds	2010/06/01	English	306
Diagnosis, Management, and Evaluation of Chemotherapy-Induced Peripheral Neuropathy	2006/02/01	English	271
Factors influencing survival in high-grade gliomas	2003/12/01	English	264
Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy	2004/04/01	English	252
The pathogenesis of mesothelioma	2002/02/01	English	244
Role of Raf Kinase in Cancer: Therapeutic Potential of Targeting the Raf/MEK/ERK Signal Transduction Pathway	2006/08/01	English	235
Post-Transplantation Cyclophosphamide for Tolerance Induction in HLA-Haploidentical Bone Marrow Transplantation	2012/12/01	English	230
Cancer in older persons: an international issue in an aging world	2004/04/01	English	224
Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia	2003/04/01	English	218
Antagonists of PD-1 and PD-L1 in Cancer Treatment	2015/08/01	English	218
Rituximab: Mechanism of action and resistance	2002/02/01	English	216
An Update on Cancer- and Chemotherapy-Related Cognitive Dysfunction: Current Status	2011/06/01	English	215
Clinical Experiences With Anti-CD137 and Anti-PD1 Therapeutic Antibodies	2010/10/01	English	210
Epidemiology of upper gastrointestinal malignancies	2004/08/01	English	210
Cancer Stem Cells: The Promise and the Potential	2015/04/01	English	209
Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development	2017/06/01	English	206
Therapy-Related Myeloid Leukemia	2008/08/01	English	205
Metabolic Positron Emission Tomography Imaging in Cancer Detection and Therapy Response	2011/02/01	English	202
Immune Checkpoint Proteins: A New Therapeutic Paradigm for Cancer—Preclinical Background: CTLA-4 and PD-1 Blockade	2010/10/01	English	200
Tumor angiogenesis and accessibility: Role of vascular endothelial growth factor	2002/12/01		194
Clinical aspects and molecular basis of oxaliplatin neurotoxicity: Current management and development of preventive measures	2002/10/01		193